FDA Approves New Animal Drug Application for Sulfamerazine, Sulfamethazine, and Sulfaquinoxaline Powder

Summary

The Food and Drug Administration (FDA) is updating its regulations to reflect the approval of a new animal drug application (NADA) submitted by Alpharma Inc. for a soluble powder containing sulfamerazine, sulfamethazine, and sulfaquinoxaline, which will be used in drinking water for chickens and turkeys to help control coccidiosis and acute fowl cholera.